Sarcopenia (Age-Related Muscle Loss) Support Protocol

Sarcopenia is the age-related loss of muscle mass, strength, and function that begins around age 30-40 and accelerates after 60. By age 80, people may lose up to 50% of their muscle mass. This leads to weakness, falls, fractures, loss of independence, and increased mortality. Multiple factors contribute: reduced physical activity, inadequate protein intake, hormonal changes, chronic inflammation, and what's called 'anabolic resistance'—aging muscles don't respond as well to the signals that normally build muscle.

IMPORTANT: Resistance exercise is the most powerful intervention for sarcopenia—supplements support but can't replace physical activity. A combination of exercise and nutritional strategies is most effective. Underlying conditions affecting muscle (diabetes, thyroid disorders, malnutrition) should be addressed.

•Protein/Whey Protein is fundamental for preventing and treating sarcopenia. Older adults need MORE protein than younger people—at least 1.0-1.2g per kilogram of body weight daily, and possibly up to 1.5g/kg. Protein should be distributed evenly across meals (25-40g per meal) rather than concentrated at dinner. Whey protein is particularly effective because it's rapidly absorbed and high in leucine.

•Creatine Monohydrate is one of the most effective supplements for older adults. It enhances muscle strength, power, and mass, especially when combined with resistance training. Creatine works by increasing the phosphocreatine energy system in muscles and may also have benefits for brain health.

•Vitamin D deficiency is extremely common in older adults and directly contributes to muscle weakness. Vitamin D receptors are present in muscle tissue, and adequate levels are needed for normal muscle function. Supplementation improves strength and reduces fall risk in deficient individuals.

•HMB is a metabolite of leucine that reduces muscle protein breakdown. It's particularly useful when people can't exercise (bed rest, illness) to help preserve muscle mass. Studies show it may help older adults maintain muscle.

•Omega-3 Fatty Acids may enhance the muscle-building response to protein intake (anabolic sensitivity) and reduce the chronic low-grade inflammation that contributes to muscle loss.

•Leucine is the key amino acid that triggers muscle protein synthesis. Older muscles need higher leucine levels to 'switch on' this process (the 'leucine threshold' concept). Taking extra leucine with meals can help overcome anabolic resistance.

•Essential Amino Acids provide all the building blocks needed for muscle protein synthesis in an easily absorbed form. They're particularly useful for people who struggle to eat enough protein.

•CoQ10 supports mitochondrial energy production in muscle cells. Levels decline with age, and supplementation may support muscle energy metabolism.

•Carnitine helps transport fatty acids into mitochondria for energy production and may reduce fatigue and improve physical function in older adults.

Expected timeline: Protein and amino acids: ongoing support. Creatine: 2-4 weeks to saturate muscle stores. Vitamin D (if deficient): 2-3 months to replenish. Best results require consistent supplementation combined with resistance exercise for 3-6 months minimum.

Clinical Perspective

Sarcopenia: EWGSOP2 definition requires low muscle strength (grip strength <27kg men/<16kg women) with low muscle quantity/quality (appendicular lean mass by DXA or BIA below cut-offs). Severe sarcopenia adds low physical performance (gait speed <0.8m/s, 5-chair stand >15 seconds, SPPB score <=8). Pathophysiology: anabolic resistance (blunted muscle protein synthesis response), reduced satellite cells, mitochondrial dysfunction, chronic inflammation (inflammaging), hormonal changes (reduced testosterone, GH, IGF-1), neuromuscular junction degeneration. Risk factors: aging, physical inactivity, malnutrition, chronic diseases (diabetes, heart failure, cancer, COPD, CKD).

CRITICAL: Resistance exercise is the primary intervention—supplements are adjunctive. Evaluation should rule out secondary causes: malnutrition, endocrine disorders (hypogonadism, hypothyroidism, diabetes), inflammatory conditions, malignancy, neurological disease. Combination of exercise + nutrition most effective. No pharmacological treatments yet approved for sarcopenia.

•Protein/Whey Protein (A-grade): Provides substrate for muscle protein synthesis. Older adults have anabolic resistance—need higher protein/leucine threshold. Systematic review: protein supplementation increases lean mass and strength (PMID: 26561618). Meta-analysis: confirms benefit especially with exercise (PMID: 28985426). 1.0-1.5g/kg/day; 25-40g per meal; include high-leucine sources. Whey rapidly absorbed; casein for sustained release.

•Creatine Monohydrate (A-grade): Increases phosphocreatine stores, enhances training capacity. Meta-analysis in older adults: creatine + resistance training increases lean mass and strength more than training alone (PMID: 24576864). Systematic review: safe and effective in aging (PMID: 29704637). 3-5g daily; no loading needed. Safe long-term.

•Vitamin D (B-grade): VDR in skeletal muscle; affects calcium handling, muscle protein synthesis. Deficiency causes myopathy. Meta-analysis: vitamin D improves muscle strength in deficient older adults (PMID: 25794194). Check 25(OH)D; target 40-60 ng/mL. 2000-4000 IU daily; higher if deficient.

•HMB (B-grade): Reduces muscle protein breakdown via mTOR and ubiquitin-proteasome pathway modulation. Meta-analysis: HMB may preserve lean mass in older adults (PMID: 29058887). 3g daily in divided doses. Most beneficial during periods of inactivity, bed rest, or in frail elderly.

•Omega-3 Fatty Acids (B-grade): May enhance anabolic response to protein (increase mTOR activation), reduce inflammation. Systematic review: omega-3s may improve muscle mass and function (PMID: 25994567). 2-4g EPA+DHA daily. Effects may take 3-6 months.

•Leucine (B-grade): Key amino acid activating mTOR-mediated muscle protein synthesis. Review: older adults need higher leucine (2.5-3g per meal) to overcome anabolic resistance (PMID: 24699855). Supplement or ensure high-leucine protein sources.

•Essential Amino Acids (B-grade): Provide all required amino acids for MPS in readily absorbed form. Systematic review: EAA supplementation improves muscle outcomes in elderly (PMID: 27708844). 6-15g daily, especially around exercise.

•CoQ10 (C-grade): Mitochondrial electron transport chain component; declines with age. Review: may support muscle energy metabolism (PMID: 26648988). 100-300mg daily. Limited direct evidence for sarcopenia.

•Carnitine (C-grade): Fatty acid transport into mitochondria. Systematic review: may improve fatigue and physical function in elderly (PMID: 17914561). 1-2g daily. Modest evidence.

Biomarker targets: Grip strength (dynamometer), gait speed, SPPB score, 5-times sit-to-stand, DXA or BIA for lean mass, functional assessments (6-minute walk, TUG test), 25(OH)D levels.

Protocol notes: Resistance exercise is primary intervention—2-3 sessions weekly targeting major muscle groups, progressive overload. Protein timing matters: distribute throughout day, post-exercise protein important. Address protein-energy malnutrition. Screen for vitamin D deficiency—very common in elderly. Consider testosterone in hypogonadal men (controversial in sarcopenia without frank deficiency). Reduce sedentary time. Address underlying diseases contributing to muscle loss. Falls prevention program. Adequate calorie intake—undereating common in elderly. Dental health affects eating ability. Social isolation affects nutrition. Physical therapy/supervised exercise programs may improve adherence. Emerging research: myostatin inhibitors, selective androgen receptor modulators (SARMs)—not yet approved. Multi-domain interventions (exercise + nutrition + cognitive) most promising for frailty.

View All Protocols